Updated Jul 16, 2026
Rubin Steven D has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $19K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | RDVT | Red Violet, Inc. | A — Grant or award | 2.2K | — | |
| 2026-05-08 | ELOX | Eloxx Pharmaceuticals, Inc. | M — Option exercise | 1.9K | — | |
| 2026-02-17 | ENTX | Entera Bio Ltd. | P — Open-market purchase | 5.0K | $1.49 | $7K |
| 2026-02-11 | ENTX | Entera Bio Ltd. | P — Open-market purchase | 10.0K | $1.20 | $12K |
| 2025-12-22 | RDVT | Red Violet, Inc. | A — Grant or award | 4.5K | — | |
| 2024-11-05 | RDVT | Red Violet, Inc. | A — Grant or award | 8.0K | — | |
| 2024-10-17 | ELOX | Eloxx Pharmaceuticals, Inc. | A — Grant or award | 12.0K | $0.00 | |
| 2024-10-11 | COCP | Cocrystal Pharma, Inc. | A — Grant or award | 19.0K | — |
Rubin Steven D is a corporate insider — currently tracked as Director of Niagen Bioscience, Inc. (NAGE). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 2 open-market purchases ($19K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Rubin Steven D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.